CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 


Hedgepath Pharmaceuticals, Inc.  (HPPI)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
 

Hedgepath Pharmaceuticals's Quick Ratio

HPPI's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Select the Comparisons : Select the Ratio:                        

HPPI Quick Ratio (Dec 31 2016)
IV. Quarter
(Sep 30 2016)
III. Quarter
(Jun 30 2016)
II. Quarter
(Mar 31 2016)
I. Quarter
(Dec 31 2015)
IV. Quarter
Y / Y Current Liabilities Change -33.3 % -13.1 % 49.77 % 30.74 % 15.22 %
Y / Y Cash & cash equivalent Change 1086.38 % 185.85 % 143.72 % 41.3 % 64.71 %
Quick Ratio MRQ 23.16 7.57 7.47 0.16 1.3
Overall Ranking # 103 # 356 # 402 # 3959 # 1666
Seq. Current Liabilities Change -34.39 % -24.03 % -16.85 % 60.94 % -14.53 %
Seq. Cash & cash equivalent Change 100.78 % -23 % 3790.54 % -80.28 % -51.62 %



Quick Ratio forth quarter 2016 Comment
Hedgepath Pharmaceuticals's Cash & cash equivalent grew by 100.78 % in IV. Quarter sequntially, while Current Liabilities decreased, this led to improvement in Hedgepath Pharmaceuticals's Quick Ratio to 23.16, Quick Ratio remained below Hedgepath Pharmaceuticals, Inc. average.

Within Biotechnology & Drugs industry 5 other companies have achieved higher Quick Ratio than Hedgepath Pharmaceuticals in forth quarter 2016. While Quick Ratio total ranking has improved so far to 103, from total ranking in previous quarter at 356.

Explain Quick Ratio?
What are HPPI Segments?
See Quick Ratio HPPI on the trailing twelve month basis
Quick Ratio forth quarter 2016 Company Ranking
Within: No.
Industry # 6
Sector # 18
S&P 500 # 103


Quick Ratio Statistics
High Average Low
23.16 3.77 0
(Dec 31 2016)   (Dec 31 2013)


You need to upgrade your Flash Player


Financial Statements
Hedgepath Pharmaceuticals's Current Liabilities $ 0 Millions Visit HPPI's Balance sheet
Hedgepath Pharmaceuticals's Cash & cash equivalent $ 7 Millions Visit HPPI's Balance sheet
Source of HPPI's Sales Visit HPPI's Sales by Geography




Companies with similar Quick Ratio in the quarter endingDec 31 2016, within Biotechnology & Drugs Industry Quick RatioDec 31 2016 MRQ Cash & cash equivalentDec 31 2016 MRQ Current Liabilities
Regenxbio Inc.  58.04 $ 89.554  Millions$ 1.543  Millions
Lion Biotechnologies, Inc.  33.51 $ 166.470  Millions$ 4.968  Millions
Kubota Pharmaceutical Holdings Co Ltd  26.52 $ 122.314  Millions$ 4.613  Millions
Atara Biotherapeutics, Inc.  26.43 $ 255.682  Millions$ 9.675  Millions
Hedgepath Pharmaceuticals, Inc.  23.16 $ 7.135  Millions$ 0.308  Millions
Adverum Biotechnologies, Inc.  22.45 $ 222.170  Millions$ 9.896  Millions
Gtx Inc  17.93 $ 21.869  Millions$ 1.220  Millions
Obalon Therapeutics Inc  16.81 $ 75.475  Millions$ 4.491  Millions
Cellular Biomedicine Group, Inc.  16.60 $ 39.252  Millions$ 2.364  Millions
Pulse Biosciences, Inc.  16.14 $ 16.395  Millions$ 1.016  Millions
Edge Therapeutics, Inc.  15.92 $ 106.399  Millions$ 6.685  Millions
Nantkwest, Inc.  15.85 $ 198.921  Millions$ 12.553  Millions
Organovo Holdings, Inc.  15.76 $ 69.996  Millions$ 4.441  Millions
Alder Biopharmaceuticals Inc  13.59 $ 351.867  Millions$ 25.890  Millions
Voyager Therapeutics, Inc.  12.64 $ 174.418  Millions$ 13.802  Millions
Wave Life Sciences Ltd.  12.36 $ 150.293  Millions$ 12.155  Millions
Aerie Pharmaceuticals Inc  12.06 $ 233.662  Millions$ 19.371  Millions
Protagonist Therapeutics, Inc.  12.06 $ 77.609  Millions$ 6.435  Millions
Cidara Therapeutics, Inc.  11.74 $ 104.619  Millions$ 8.909  Millions
Idera Pharmaceuticals, Inc.  11.66 $ 109.014  Millions$ 9.353  Millions
Eiger Biopharmaceuticals, Inc.  11.33 $ 59.936  Millions$ 5.288  Millions
Sangamo Therapeutics, Inc  10.72 $ 142.535  Millions$ 13.291  Millions
Genocea Biosciences, Inc.  10.23 $ 63.362  Millions$ 6.192  Millions
Neurocrine Biosciences Inc  10.11 $ 307.350  Millions$ 30.414  Millions
Spark Therapeutics, Inc.  9.87 $ 296.166  Millions$ 29.998  Millions
Anavex Life Sciences Corp.  9.78 $ 21.161  Millions$ 2.163  Millions
Bluebird Bio, Inc.  9.45 $ 704.378  Millions$ 74.533  Millions
Momenta Pharmaceuticals Inc  9.35 $ 353.151  Millions$ 37.781  Millions
Intellia Therapeutics, Inc.  8.89 $ 273.064  Millions$ 30.730  Millions
Acceleron Pharma Inc  8.65 $ 139.690  Millions$ 16.149  Millions
Economy

Advance Monthly Sales
Consumer Price Index CPI
Producer Price Index PPI
Retail Inventories
Personal Income
Gross Domestic Product GDP
Money Supply
Industrial Production
Productivity
Employment Situation
US International Trade
Factory Orders
Durable Goods
Construction Spending
Housing Starts
Vehicle Unit Sales
Stocks

Event Calendar
GBSN's Profile
Stock Price
GBSN's Financials
GBSN's Expectations
Business Description
Fundamentals
Charts & Quotes
GBSN's News
Suppliers
GBSN's Competitors
Customers & Markets
Economic Indicators
GBSN's Growth
Company Segments
Industries

At a Glance
Performance
Growth Rates
Profitability
Valuation
Financial Strength
Markets

At a Glance
Stocks
Indices
Sectors & Industries
Financials
Commodities
Currencies
Screening

Stock Performance
Growth Rates
Profitability
Valuation
Dividend
Financial Strength
Efficiency
Expectations
Management Effectivness
News

At a Glance
Stocks
Economy
Industries
Other
Glossary

Financial Terms
Technical Analysis
Fundamental Analysis
Energy Terms
Manufacturing Terms
Transportation Terms
Health Care
Insurance Terms
Economy Terms
Hotel & Leisure Terms
Help

Sitemap
Advertise
About us
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2017 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com